A Multicenter, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of Evolocumab
A Multicenter, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of Evolocumab
The purpose of this study was to characterize the safety and tolerability of long-term administration of evolocumab in adults with known coronary artery disease and hypercholesterolemia.
Inclusion Criteria:
Exclusion Criteria:
Rozzano MI, 20089, Italy
Seongnam-si, Gyeonggi-do, 463-707, South Korea